These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9669469)

  • 41. [Randomized controlled clinical trial of middle-dose cyclophosphamide plus methylprednisolone for myasthenia gravis patients in crisis].
    Feng HY; Liu WB; Qiu L; Huang X; Luo CM; Li Y; Wang HY
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(35):2473-6. PubMed ID: 23158712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of high-dose intravenous methylprednisolone pulse (IVMP) therapy in the survival of patients with anti-melanoma differentiation-associated gene 5-related rapidly progressive interstitial lung disease: a retrospective analysis.
    Fan L; Li Y; Lyu W; Xu Q; Gao Y; Qiu X; Cai H; Dai J
    Clin Rheumatol; 2024 Mar; 43(3):1135-1143. PubMed ID: 38289569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anti-acetylcholine receptor antibodies: effect of immunosuppressive drug therapy in patients with myasthenia gravis].
    Sidnev DV; Sanadze AG; Dedaev SI; Karganov MIu; Alchinova IB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 1):37-40. PubMed ID: 21183922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Myasthenia gravis: life-saving effect of a massive dose of intravenous methylprednisolone].
    Szobor A; Bárdosi Z; Klátyik M; Klein M
    Orv Hetil; 1988 Mar; 129(10):495-6, 499. PubMed ID: 3362539
    [No Abstract]   [Full Text] [Related]  

  • 45. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
    Palace J; Newsom-Davis J; Lecky B
    Neurology; 1998 Jun; 50(6):1778-83. PubMed ID: 9633727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis.
    Tindall RS; Rollins JA; Phillips JT; Greenlee RG; Wells L; Belendiuk G
    N Engl J Med; 1987 Mar; 316(12):719-24. PubMed ID: 3547126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized Trial of Thymectomy in Myasthenia Gravis.
    Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
    N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP.
    Nobile-Orazio E; Cocito D; Jann S; Uncini A; Messina P; Antonini G; Fazio R; Gallia F; Schenone A; Francia A; Pareyson D; Santoro L; Tamburin S; Cavaletti G; Giannini F; Sabatelli M; Beghi E;
    J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):729-34. PubMed ID: 25246645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
    Punga AR; Flink R; Askmark H; Stålberg EV
    Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rituximab in the management of refractory myasthenia gravis.
    Zebardast N; Patwa HS; Novella SP; Goldstein JM
    Muscle Nerve; 2010 Mar; 41(3):375-8. PubMed ID: 19852027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial.
    Meduri GU; Headley AS; Golden E; Carson SJ; Umberger RA; Kelso T; Tolley EA
    JAMA; 1998 Jul; 280(2):159-65. PubMed ID: 9669790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Steroid pulse therapy].
    Miura M
    Nihon Rinsho; 2014 Sep; 72(9):1631-5. PubMed ID: 25518414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Intermittent methylprednisolone pulse therapy for myasthenia gravis in childhood].
    Tanaka J; Matsuzaki K; Arai H; Nagai T; Matsumoto Y; Okada S
    No To Hattatsu; 1994 Jan; 26(1):14-9. PubMed ID: 8280441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decompensating esophoria as the presenting feature of myasthenia gravis.
    Arblaster GE; Shipman TL; Pepper IM
    J AAPOS; 2009 Jun; 13(3):310-1. PubMed ID: 19395293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short-term combination of glatiramer acetate with i.v. steroid treatment preceding treatment with GA alone assessed by MRI-disease activity in patients with relapsing-remitting multiple sclerosis.
    De Stefano N; Filippi M; Hawkins C;
    J Neurol Sci; 2008 Mar; 266(1-2):44-50. PubMed ID: 17897678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of chronic inflammatory demyelinating polyneuropathy with high dose intravenous methylprednisolone monthly for five years: 10-Year follow up.
    Börü ÜT; Erdoğan H; Alp R; Taşdemir M; Yıldırım S; Bilgiç A; Duman A; Arslan A
    Clin Neurol Neurosurg; 2014 Mar; 118():89-93. PubMed ID: 24529237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.
    Liu S; Liu X; Chen S; Xiao Y; Zhuang W
    PLoS One; 2017; 12(11):e0188644. PubMed ID: 29176905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.
    Hehir MK; Hobson-Webb LD; Benatar M; Barnett C; Silvestri NJ; Howard JF; Howard D; Visser A; Crum BA; Nowak R; Beekman R; Kumar A; Ruzhansky K; Chen IA; Pulley MT; LaBoy SM; Fellman MA; Greene SM; Pasnoor M; Burns TM
    Neurology; 2017 Sep; 89(10):1069-1077. PubMed ID: 28801338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crisis, precrisis and drug resistance in myasthenia gravis.
    Glaser GH
    Ann N Y Acad Sci; 1966 Jan; 135(1):335-49. PubMed ID: 5221348
    [No Abstract]   [Full Text] [Related]  

  • 60. Myasthenia gravis associated with lupus nephritis.
    Lee H; Chen W; Su K; Chou C; Tsai C
    Lupus; 2008 Sep; 17(9):860-1. PubMed ID: 18755870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.